当前位置: X-MOL 学术Arthritis Rheumatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
Arthritis & Rheumatology ( IF 11.4 ) Pub Date : 2022-06-20 , DOI: 10.1002/art.42140
Susan M Goodman 1 , Bryan D Springer 2 , Antonia F Chen 3 , Marshall Davis 4 , David R Fernandez 1 , Mark Figgie 1 , Heather Finlayson 5 , Michael D George 6 , Jon T Giles 7 , Jeremy Gililland 8 , Brian Klatt 9 , Ronald MacKenzie 1 , Kaleb Michaud 10 , Andy Miller 1 , Linda Russell 1 , Alexander Sah 11 , Matthew P Abdel 12 , Beverly Johnson 13 , Lisa A Mandl 1 , Peter Sculco 1 , Marat Turgunbaev 14 , Amy S Turner 14 , Adolph Yates 9 , Jasvinder A Singh 15
Affiliation  

To develop updated guidelines for the perioperative management of disease-modifying medications for patients with rheumatic diseases, specifically those with inflammatory arthritis (IA) and those with systemic lupus erythematosus (SLE), undergoing elective total hip arthroplasty (THA) or elective total knee arthroplasty (TKA).

中文翻译:

2022 年美国风湿病学会/美国髋关节和膝关节外科医生协会指南:风湿病患者接受择期全髋关节或全膝关节置换术的围手术期管理抗风湿药物

为风湿性疾病患者,特别是炎症性关节炎 (IA) 患者和系统性红斑狼疮 (SLE) 患者、接受择期全髋关节置换术 (THA) 或择期全膝关节置换术的患者制定更新的围手术期管理疾病改善药物指南(TKA)。
更新日期:2022-06-20
down
wechat
bug